Pulmozyme Solution
Product Images NDC 50242-100

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Pulmozyme (NDC 50242-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pulmozyme 01)

A line graph showing mean percent change over study days comparing placebo treatment (crosses), rhDNase 2.5 mg once daily (open triangles), and rhDNase 2.5 mg twice daily (solid circles). The x-axis represents study days from baseline to 169, and the y-axis shows mean percent change values ranging from -5 to 10.*

FDA Label Image

Figure A (Pulmozyme 02)

Illustration showing components for Pulmozyme (dornase alfa) inhalation solution administration. Items depicted include Pulmozyme ampule, compressor, long connecting tube, nebulizer cup and cap, flexible aerosol tube, plastic T, mouthpiece, nose clip, and PARI BABY facemask, labeled as Figure A.*

FDA Label Image

Figure B (Pulmozyme 03)

An instructional illustration labeled as Figure B showing a hand holding a respiratory inhalation device with the mouthpiece inserted between the fingers and the thumb positioned for use. The image demonstrates proper hand placement for administering an inhaled medication.*

FDA Label Image

Figure C (Pulmozyme 04)

An instructional diagram labeled Figure C showing a hand pressing the On/Off button on a medical device with an air outlet labeled. This illustration is related to the operation of a device used for respiratory inhalation treatment.*

FDA Label Image

Figure D (Pulmozyme 05)

An instructional illustration labeled Figure D showing hands opening a package containing three ampules. The image indicates the expiration date location on the package and demonstrates the process of opening an ampule for use.*

FDA Label Image

Figure E (Pulmozyme 06)

An instructional illustration showing a hand holding a Pulmozyme (dornase alfa) ampule. The image indicates the correct way to snap off the top of the ampule, with arrows pointing to the breaking point.*

FDA Label Image

Figure F (Pulmozyme 07)

An instructional diagram labeled Figure F showing a tube with an air outlet. The tube is connected at the bottom, and the air out flow is indicated by an arrow pointing away from the tube.*

FDA Label Image

Figure G (Pulmozyme 08)

Instructional illustration labeled Figure G demonstrating how to twist a plastic T-junction from a mouthpiece for respiratory solution administration. The image shows hands manually adjusting the plastic T and the mouthpiece component.*

FDA Label Image

Figure H (Pulmozyme 09)

An instructional line drawing showing a nebulizer cup labeled with a cap. The illustration highlights the cap component on top of the nebulizer cup, commonly used for respiratory inhalation solutions like Pulmozyme.*

FDA Label Image

Figure I (Pulmozyme 10)

An instructional illustration showing components of a nebulizer system, specifically labeled as a nebulizer cup and cap. The image is titled Figure I and depicts a simple line drawing of these two parts used in respiratory inhalation therapy.*

FDA Label Image

Figure J (Pulmozyme 11)

Instructional diagram titled Figure J demonstrating the use of hands to twist and remove the top part of a syringe or inhalation device, indicated by an arrow and the word 'top' to show the direction of movement.*

FDA Label Image

Figure K (Pulmozyme 12)

An instructional illustration labeled 'Figure K,' showing a hand placing a dropper-like unit into a bottle with a small cap nearby, likely demonstrating part of the preparation or use of Pulmozyme (dornase alfa) solution for respiratory inhalation.*

FDA Label Image

Figure L (Pulmozyme 13)

An instructional line drawing labeled 'Figure L' illustrating a respiratory inhalation device. The image identifies and points to two parts of the device: the 'cap' on top and the 'nebulizer cup' below it.*

FDA Label Image

Figure M (Pulmozyme 14)

An instructional illustration labeled Figure M showing a hand holding a vial and using a plastic T-shaped tool to remove the cap from the vial.*

FDA Label Image

Figure N (Pulmozyme 15)

Black and white instructional illustration showing a hand holding a respiratory inhaler device with the mouthpiece labeled. The image is labeled 'Figure N' and appears to demonstrate how to position or hold the mouthpiece during use.*

FDA Label Image

Figure O (Pulmozyme 16)

An instructional diagram labeled Figure O showing the use of a mask and an elbow connector for respiratory inhalation administration. The image illustrates assembling or using the inhalation device components.*

FDA Label Image

Figure P (Pulmozyme 17)

An instructional illustration labeled 'Figure P' showing a hand attaching or holding a small bottle-like container connected to a tube. This diagram likely demonstrates part of the respiratory inhalation process or device setup relevant to the product Pulmozyme (dornase alfa) solution for inhalation.*

FDA Label Image

Figures Q (Pulmozyme 18)

An instructional illustration labeled 'Figure Q' showing a hand holding an inhalation device emitting a mist, demonstrating the correct method for administering a respiratory solution inhalation.*

FDA Label Image

Figure S (Pulmozyme 20)

An instructional illustration labeled Figure R, showing a person inhaling from a device or inhaler held near the mouth. The image visually demonstrates the proper inhalation technique for a respiratory medication.*

FDA Label Image

Figure T (Pulmozyme 21)

An instructional illustration showing a person using a respiratory inhalation device with a nose clip in place. The image focuses on proper inhalation technique, highlighting the use of the nose clip during administration.*

FDA Label Image

Figure U (Pulmozyme 22)

An instructional illustration labeled 'Figure T' depicting a person holding an inhalation device to their mouth, demonstrating the proper technique for using a respiratory solution inhaler, likely related to Pulmozyme (dornase alfa) inhalation solution.*

FDA Label Image

Figure V (Pulmozyme 23)

An instructional illustration labeled as Figure U showing a person removing the cap from a Pulmozyme inhalation device. The hand is gripping the device while lifting off the cap, demonstrating the first step in preparing the device for use.*

FDA Label Image

Figure W (Pulmozyme 24)

An instructional diagram showing a person using an inhalation device with a mask positioned over the nose and mouth. The diagram labels the mask and elbow connector parts of the inhalation apparatus, guiding proper assembly or use.*

FDA Label Image

Figure X (Pulmozyme 25)

An instructional diagram labeled 'Figure W' showing a hand holding a Pulmozyme inhalation device with a mouthpiece, demonstrating the proper way to use the respiratory solution by inhalation.*

FDA Label Image

Figure Y (Pulmozyme 26)

An instructional diagram showing a hand removing the cap from a Pulmozyme (dornase alfa) inhalation solution vial. The illustration highlights the action of lifting the cap straight up off the vial, labeled as 'Figure X.'*

FDA Label Image

Figure A (Pulmozyme 27)

Illustration showing components of the Pulmozyme inhalation treatment system including a Pulmozyme ampule, a nose clip, the eRapid Nebulizer System with labeled parts (handset, medication reservoir, medication cap, mouthpiece, On/Off button, controller, and light), the manufacturer's eRapid Nebulizer System instruction booklet, an AC power supply, and four AA batteries.*

FDA Label Image

Figure B (Pulmozyme 28)

An instructional illustration labeled Figure B showing the use of an inhalation device. The diagram depicts a hand holding a respiratory inhalation apparatus, demonstrating its application technique for drug delivery to the respiratory system.*

FDA Label Image

Figure C (Pulmozyme 29)

An instructional diagram labeled "Figure C" showing a power supply with a cord plugged into an electrical outlet. The outlet is a standard dual socket type, and a label indicates the "outlet" and "power supply." The image demonstrates the connection of the power supply to the electrical outlet.*

FDA Label Image

Figure D (Pulmozyme 30)

An illustration labeled Figure D showing a close-up of a respiratory therapy device controller with a hand pressing an On/Off button.*

FDA Label Image

Figure E (Pulmozyme 31)

An instructional illustration labeled Figure E demonstrating the correct method of breaking an ampule. The image shows hands holding an ampule near the top, with an arrow indicating a snapping motion, alongside a bag below. The expiration date is noted to be checked on the ampule.*

FDA Label Image

Figure F (Pulmozyme 32)

An instructional illustration labeled Figure F showing hands holding a Pulmozyme (dornase alfa) ampule with arrows indicating the direction to snap open the ampule at the neck, demonstrating how to prepare the solution for respiratory inhalation.*

FDA Label Image

Figure G (Pulmozyme 33)

An instructional illustration depicting parts of a respiratory inhalation device for Pulmozyme (dornase alfa) solution. It includes a booklet labeled 'eRapid,' a control unit, and various detachable components for assembly or use.*

FDA Label Image

Figure H (Pulmozyme 34)

An instructional illustration labeled Figure H showing a hand holding a cylindrical device labeled 'top' with another hand pulling off a cap or cover from the top. The image likely pertains to the preparation or use of a respiratory inhalation solution device.*

FDA Label Image

Figure I (Pulmozyme 35)

An instructional diagram labeled Figure I illustrating how to attach the medication reservoir to the handset of a respiratory inhalation device for Pulmozyme (dornase alfa). The image highlights a hand placing the medication reservoir onto the handset, with the medication cap shown separately nearby.*

FDA Label Image

Figure J (Pulmozyme 36)

An instructional diagram labeled Figure J showing a medication cap on top of a device used for respiratory inhalation. The image highlights the medication cap placement on the inhalation device, part of the delivery system for Pulmozyme (dornase alfa) solution.*

FDA Label Image

Figure K (Pulmozyme 37)

An instructional illustration labeled as Figure K showing a hand pressing the On/Off button on the top surface of a Pulmozyme device, used for respiratory inhalation of dornase alfa solution. The image focuses on how to operate the On/Off button on the device.*

FDA Label Image

Figure L (Pulmozyme 38)

An instructional diagram showing a respiratory inhalation device setup for Pulmozyme (dornase alfa) solution. The figure highlights key components including the nebulizer mouthpiece producing mist and a light indicator on the device base, illustrating the device in operation for inhalation treatment.*

FDA Label Image

Figure M (Pulmozyme 39)

An instructional illustration showing a side view of a person using a respiratory inhalation device. The device is held by the person, with a mouthpiece directed into their mouth. The figure is labeled 'Figure M'.*

FDA Label Image

Figure N (Pulmozyme 40)

An instructional illustration showing a person holding a nose clip and placing it on their nose, with a device positioned near their mouth, likely demonstrating the use of a respiratory inhalation solution device.*

FDA Label Image

Figure O (Pulmozyme 41)

An instructional illustration labeled 'Figure O' showing a hand pressing the On/Off button on a circular medical device, likely related to the administration of Pulmozyme (dornase alfa) solution for respiratory inhalation.*

FDA Label Image

Figure P (Pulmozyme 42)

An instructional diagram showing the measurement of approximately 1/5 teaspoon (1 mL) of solution, likely for dosing or administration. The image highlights a specific portion of a device or container with a detailed inset marking the 1 mL level.*

FDA Label Image

Figure Q (Pulmozyme 43)

An instructional illustration labeled 'Figure Q' depicting a booklet associated with the Pulmozyme eRapid respiratory inhalation solution. The booklet appears to be part of the patient training or usage guide accompanied by the Pulmozyme eRapid device.*

FDA Label Image

Principal Display Panel (2.5 mL Ampule Pouch Carton)

Label for Pulmozyme inhalation solution containing dornase alfa. The label highlights the product name prominently and instructs to keep refrigerated. Manufactured by Genentech, Inc., with address in South San Francisco, CA, and U.S. License No. 1048. The NDC number 50242-100-40 appears at the top right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.